<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13089">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01664507</url>
  </required_header>
  <id_info>
    <org_study_id>Croup_01</org_study_id>
    <nct_id>NCT01664507</nct_id>
  </id_info>
  <brief_title>The Effect and Safety of Low Dose Nebulized Epinephrine in Croup</brief_title>
  <official_title>The Effect and Safety of Low Dose Nebulized Epinephrine in the Treatment of Croup</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Croup is common illness presenting emergency department with dyspnea. The main treatment for
      croup is nebulized L-epinephrine and steroid. The study for the dose of nebulized
      L-epinephrine is restricted that the study of comparision between racemic epinephrine and
      L-epinephrine.

      The investigators conducted this study to compare the effectiveness of low dose
      L-epinephrine with conventional dose L-epinephrine.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>the difference of Westley croup score between baseline and 30 minutes after neublized treatment</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of use of additional neublized treatment</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Westley croup score</measure>
    <time_frame>30, 60, 90, 120, 180, 240 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the side effect of epinephrine</measure>
    <time_frame>participants will be followed for the duration of ED stay</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Hypertension, tachycardia : more than 95th percentile for age Arrythmia Pallor Tremor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory rate, oxygen saturation</measure>
    <time_frame>30, 60, 90, 120, 180, 240 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health care utilization- length of stay in emergency department, admission rate, revisit dut to croup symptom</measure>
    <time_frame>within 7 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>treatment failure</measure>
    <time_frame>30min after 2nd epinephrine nebulizer</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>after additional nebulized epineprhine at 30 minutes, as the croup scrore is higher than baselin, the blinding is cleared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rebound effect</measure>
    <time_frame>180 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>the croup score is the same or over than the base line</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Croup</condition>
  <condition>Epinephrine Neublizer Treatment</condition>
  <arm_group>
    <arm_group_label>conventional dose epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>low dose epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>conventional dose epinephrine</intervention_name>
    <description>conventional dose epinephrine : 0.5mg/kg + 0.9% normal saline</description>
    <arm_group_label>conventional dose epinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low dose epinephrine</intervention_name>
    <description>low dose epineprhine : 0.05mg/kg + normal saline</description>
    <arm_group_label>low dose epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  croup children between 6 month and 5 years old

          -  Westley croup score between 3 and 11

        Exclusion Criteria:

          -  underlying lung or heart disase

          -  contra indication to dexamethasone

          -  immune deficient state

          -  preterm birth

          -  previous intubation or apnea history
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 9, 2012</lastchanged_date>
  <firstreceived_date>August 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin Hee Lee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>croup, dose, epinephrine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Croup</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
